Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.2 added, replacing the previous v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a resources section linking to the Genetic and Rare Diseases Information Center and included 'Small cell lung carcinoma' as a related term on the page.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision: v3.5.0 has been applied, replacing v3.4.3. This appears to be a general site version upgrade rather than changes to study data or page content.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.1%

- Check71 days agoChange DetectedSite revision updated to v3.4.2; funding-status notice (v3.4.1) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedAdded a government funding lapse notice with links for status updates and updated the site revision to v3.4.1 (replacing the previous v3.4.0 revision).SummaryDifference0.5%

Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.